Ed has sold 2 private companies, Affinium, and Karos; established the Rare Disease Research Unit at PFE; founded 3 companies; led multiple private financings and business development transactions; been on the faculty of Harvard Medical School; has a MS from MIT; and a MD from UMass Medical School.